News
The Case for Digital Pill Use in Clinical Trials
8/17/2021
Those who design and run clinical trials often worry about medication adherence among trial participants. Nonadherence is a significant concern in all types of clinical...
Read More
etectRx Announces Eric Buffkin as New CEO
7/30/2021
Company Founder Takes the Helm of etectRx, a Digital Health Company GAINESVILLE, Fla. (August 2, 2021) – etectRx™, Inc. (etectRx™), a privately held digital health...
Read More
The Future of Digital Pills: A Fireside Chat Featuring Valerie Sullivan
5/21/2021
etectRx CEO Valerie Sullivan recently joined Impetus Digital’s Natalie Yeadon in a Fireside Chat to talk about the use of digital pills in healthcare and...
Read More
PODCAST: Inspiring Women with Laurie McGraw and Valerie Sullivan
5/13/2021
etectRx CEO Valerie Sullivan recently spoke with Laurie McGraw, host of the Inspiring Women podcast about the importance of asking for things, practicing, and knowing...
Read More
WHITEPAPER: The Extraordinary Problem of Medication Nonadherence in Oncology Patients And How Digital Pills Can Make a Difference
5/4/2021
Cancer is often highly treatable due to new therapies, especially oral agents, that have improved outcomes and survival rates, and allow patients to be treated...
Read More
etectRx Announces Launch of MyTPill Study to Address Medication Adherence Among HIV+ Prescription Opioid Users
5/4/2021
GAINESVILLE, Fla. & BOSTON, Mass. (May 4, 2021) – Digital health company, etectRx, Inc., today announced the launch of a study to monitor antiretroviral therapy...
Read More
etectRx “It Already Does That”
4/30/2021
Inspiration struck the etectRx team after watching the Apple Watch Series 6 – “It Already Does That” campaign. etectRx enthusiastically created its version of “It...
Read More
A Brief Training Program to Support the Use of a Digital Pill System for Medication Adherence: Pilot Descriptive Study
4/23/2021
In partnership with our collaborators at academic medical centers in the United States, etectRx has created a simple and streamlined training program for our FDA-cleared...
Read More
The ID-Cap™ System: A Physician’s Perspective
4/14/2021
“The overall experience of our study participants so far with the ID-Cap System has been very positive. They have been able to navigate it quite...
Read More
High Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic
4/12/2021
COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from...
Read More
Digital Pill Study Shows Significant Impact on Hepatitis C Treatment Adherence and Efficacy
3/5/2021
A study conducted between August 2017 and April 2019 with 288 participants for hepatitis C virus (HCV) treatment evaluated the impact of a digital medicine...
Read More
PODCAST: Digesting Digital Medicine: Healthcare Benefits When Smart Pills Track When Taken
3/4/2021
Joe Selvaggi, host of The HubWonk podcast, interviewed our CEO Valerie Sullivan about the significance of digital pill technology and how it can enhance the pharma ecosystem....
Read More